Lake Street Maintains Buy on Cellebrite DI, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Frank Takkinen maintains a Buy rating on Cellebrite DI (NASDAQ:CLBT) and raises the price target from $13.5 to $17.
August 16, 2024 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lake Street analyst Frank Takkinen maintains a Buy rating on Cellebrite DI and raises the price target from $13.5 to $17.
The raised price target from $13.5 to $17 and maintained Buy rating by a reputable analyst is likely to positively impact investor sentiment and drive short-term price appreciation for CLBT.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100